斥资18亿美元！礼来扩建爱尔兰工厂，加大减肥药生产

华尔街见闻09-12

礼来公司在爱尔兰建厂，扩产减肥药，全力以赴满足其药品不断增长的需求。 9月12日周四，彭博社报道，美国制药巨头礼来公司计划斥资10亿美元扩建位于爱尔兰利默里克的现有工厂，还将斥资8亿美元在爱尔兰科克郡金赛尔镇的工厂建造新设施，努力满足其明星药物Mounjaro和Zepbound的市场需求。自2022年起，药物供应就出现了短缺。金赛尔镇工厂的新设施将用来生产礼来公司药物注射笔中的活性成分...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2466885203?lang=zh_CN&edition=full","thumbnail":"https://wpimg-wscn.awtmt.com/8cad0f48-6a49-4781-b8b9-a6be3ce797bb.png","is_english":false,"pubTime":"2024-09-12 21:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2466885203","market":"hk","top_or_hot":-1,"title":"斥资18亿美元！礼来扩建爱尔兰工厂，加大减肥药生产","media":"华尔街见闻","content":"<div>\n<p>礼来公司在爱尔兰建厂，扩产减肥药，全力以赴满足其药品不断增长的需求。\n9月12日周四，彭博社报道，美国制药巨头礼来公司计划斥资10亿美元扩建位于爱尔兰利默里克的现有工厂，还将斥资8亿美元在爱尔兰科克郡金赛尔镇的工厂建造新设施，努力满足其明星药物Mounjaro和Zepbound的市场需求。自2022年起，药物供应就出现了短缺。\n金赛尔镇工厂的新设施将用来生产礼来公司药物注射笔中的活性成分...</p>\n\n<a href=\"https://wallstreetcn.com/articles/3727852\">网页链接</a>\n\n</div>\n","source":"wallstreetcn_hot_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>斥资18亿美元！礼来扩建爱尔兰工厂，加大减肥药生产</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n斥资18亿美元！礼来扩建爱尔兰工厂，加大减肥药生产\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-12 21:39 北京时间&nbsp;&nbsp;&nbsp;<a href=https://wallstreetcn.com/articles/3727852><strong>华尔街见闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>礼来公司在爱尔兰建厂，扩产减肥药，全力以赴满足其药品不断增长的需求。\n9月12日周四，彭博社报道，美国制药巨头礼来公司计划斥资10亿美元扩建位于爱尔兰利默里克的现有工厂，还将斥资8亿美元在爱尔兰科克郡金赛尔镇的工厂建造新设施，努力满足其明星药物Mounjaro和Zepbound的市场需求。自2022年起，药物供应就出现了短缺。\n金赛尔镇工厂的新设施将用来生产礼来公司药物注射笔中的活性成分...</p>\n\n<a href=\"https://wallstreetcn.com/articles/3727852\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1035775433.USD","symbol_name":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (USD) INC","start_time":0,"source_url":"https://wallstreetcn.com/articles/3727852","article_id":"2466885203","we_media_id":null,"thumbnails":["https://wpimg-wscn.awtmt.com/8cad0f48-6a49-4781-b8b9-a6be3ce797bb.png"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3727852","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2466885203","pubTimestamp":1726148365,"sourceInfo":{"source_id":"wallstreetcn_hot_news","name":"华尔街见闻"},"weMediaInfo":null,"summary":"礼来的减肥药被认为是历史上最畅销的药物之一。本次，礼来计划斥资10亿美元扩建位于爱尔兰利默里克的现有工厂，还将斥资8亿美元在爱尔兰科克郡金赛尔镇的工厂建造新设施，努力满足其明星药物Mounjaro和Zepbound的市场需求。","collect":0,"end_time":0,"defaultTopTitle":"wallstreetcn.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1035775433.USD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (USD) INC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","LU0094547139.USD":"abrdn SICAV I - GLOBAL SUSTAINABLE EQUITY FUND \"A\" (USD) ACC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU0385154629.USD":"贝莱德营养科学基金A2","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","BK4534":"瑞士信贷持仓","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","IE0004445239.USD":"JANUS HENDERSON US FORTY \"A2\" (USD) ACC","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","IE00BJLML261.HKD":"HSBC GLOBAL EQUITY INDEX \"HCH\" (HKD) ACC","BK4585":"ETF&股票定投概念","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","LU1069344957.HKD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (HKD) INC","BK4516":"特朗普概念","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","IE00BK4W5L77.USD":"HSBC GLOBAL FUNDS ICAV US EQUITY INDEX \"HC\" (USD) ACC","BK4007":"制药","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","LU0471298694.HKD":"BGF NUTRITION \"A2\" (HKD) ACC","LU0006306889.USD":"SCHRODER ISF US LARGE CAP \"A\" (USD) INC AV","IE00BK4W5M84.HKD":"HSBC GLOBAL FUNDS ICAV US EQUITY INDEX \"HC\" (HKD) ACC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU0097036916.USD":"贝莱德美国增长A2 USD","LU0466842654.USD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"A\" (USD) ACC","LU0109391861.USD":"富兰克林美国机遇基金A Acc","LU0882574055.USD":"富达全球健康医疗A ACC","LU0122379950.USD":"贝莱德世界健康科学A2","LU0096364046.USD":"CT (LUX) I AMERICAN \"DU\" (USD) ACC","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LLY":"礼来","LU0058720904.USD":"联博国际健康护理基金A","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU0708995401.HKD":"FRANKLIN U.S. OPPORTUNITIES \"A\" (HKD) ACC","LU0079474960.USD":"联博美国增长基金A","LU0354030511.USD":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC","BK4588":"碎股","LU0882574139.USD":"富达环球消费行业基金A ACC"},"translate_title":"Spend $1.8 billion! Eli Lilly expands Irish plant, ramps up production of weight loss pills","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LLY":0.9},"content_text":"礼来公司在爱尔兰建厂，扩产减肥药，全力以赴满足其药品不断增长的需求。\n9月12日周四，彭博社报道，美国制药巨头礼来公司计划斥资10亿美元扩建位于爱尔兰利默里克的现有工厂，还将斥资8亿美元在爱尔兰科克郡金赛尔镇的工厂建造新设施，努力满足其明星药物Mounjaro和Zepbound的市场需求。自2022年起，药物供应就出现了短缺。\n金赛尔镇工厂的新设施将用来生产礼来公司药物注射笔中的活性成分tirzepatide。公司执行副总裁兼制造部门负责人Edgardo Hernandez在声明中表示：\n\n“这些投资将提高我们部分药物的产量，帮助数百万人，但们不会止步于此——这些先进的设施还将支持我们研发管线分子。”\n\n根据国际制药工程协会的说法，礼来采用了混合制造方法，既增加了产量，又减小了生产精密肽类药物的困难。礼来的新设施因其创新性被评为“年度最佳设施”。\n爆炸性的需求\n近年来，减肥药市场需求广阔、供不应求，礼来的减肥药被认为是历史上最畅销的药物之一。\n2020年以来，礼来已投入超过170亿美元用于开发新工厂并扩建现有设施，礼来员工称这是近150年历史上“最雄心勃勃的制造扩展”。\n另一位减肥“双雄”诺和诺德也同样投入了数十亿美元，以增加其药物的生产能力。\n不仅在爱尔兰，礼来在全球的新工厂都将支持减肥药物的生产，产品包括活性成分、注射设备等，涵盖供应链的全部环节。\n预计到本世纪末，减肥药市场的规模将达到1300亿美元，礼来和诺和诺德都在竞相生产这些药物，但到目前为止，它们都没能跟上需求的步伐。\n目前，产能短缺阻碍了诺和诺德推出其口服减肥药；药物短缺已经导致患者开始寻找替代药物，并阻碍了希望开始使用这些药物的人们；同时，有限的供应还推迟了这些减肥药在新国家的推出。\n据彭博社报道，礼来近期计划推出Zepbound药瓶，应该能缓解部分供应短缺。同时，礼来还在推进下一代减肥药的生产，但是这些药物仍处于临床实验阶段。Hernandez表示：\n\n“这是我们从未做过的事情，但我们快速行动，确保能为未来做好准备。”\n风险提示及免责条款\n\n            市场有风险，投资需谨慎。本文不构成个人投资建议，也未考虑到个别用户特殊的投资目标、财务状况或需要。用户应考虑本文中的任何意见、观点或结论是否符合其特定状况。据此投资，责任自负。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"Product Release","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.0","shortVersion":"4.28.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2466885203"}